Condition: Prostate Cancer · Sponsor: National Taiwan University Hospital
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells. Hormone therapy can fight prostate cancer by androgen deprivation. It is not yet known if neoadjuvant radiation therapy is a more effective therapy for high-risk prostate cancer. PURPOSE: Two-stage randomized trial to compare the effectiveness and safety of neoadjuvant radiotherapy and hormone therapy followed by radical prostatectomy in men with high-risk locally advanced prostate cancer
This description comes directly from the study's public registry record.
Chi-Shin Tseng, MD · +886223123456 · clifford1987tcs@gmail.com
Always discuss trial participation with your own doctor first.
| National Taiwan University Hospital Yunlin Branch | Douliu City/Huwei Township, Yunlin County, Taiwan | Recruiting |
| National Taiwan University Hospital | Tapiei, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04894188